泰宗生物科技股份有限公司 Approved
最後更新時間 2025/07/11 , 01:38 AM
最後更新時間 2025/07/11 , 01:38 AM
負責人
Xu,Huan-Qing
統一編號
16307131
成立日期
1998/02/20
資本額
NT$800,000,000
實收資本額
NT$590,486,120
股票代號
4169
電話
02-26972628
地址
24-8F, No. 97, Sec. 1, Sintai 5th Rd., Xizhi Dist., New Taipei City, 221, Taiwan
董監事
姓名 職稱 持有股份 代表法人
Xu,Huan-Qing Chairman 12.64%
Green Partner Investments Limited Director 10.93%
Chen,Ci-Pei Director 3.58%
Chen,Jin-Ji Director 0.00%
Wang,Ya-Jun Director 0.44%
Guo,Zheng-Hong Independent Director 0.00%
Chen,Hui-You Independent Director 0.00%
Liu,Heng-Yi Independent Director 0.00%
Xu,Yi-Fang Director 0.00%
營業項目
  • Wholesale of Other Machinery and Equipment(464914)
  • Retail Sale via Mail Order Houses or via Internet(487112)
  • Retail Sale via Mail Order Houses or via Internet(487199)
  • 公司歷程
  • Change Capital to 800,000,000
    2020/07/09
  • 員工人數
    財務報表
    項目 2024 2023 2022
    Operating income 329,939 969,619 802,421
    Operating cost 162,564 489,451 353,933
    Profit (loss) of initial recognition of biological asset and agricultural products - - -
    Profit (loss) on changes in fair value less costs to sell of biological asset for current period - - -
    Operating gross profit (loss) 167,375 480,168 448,488
    Unrealized profit (loss) on sales of goods - - -
    Realized profit (loss) on sales of goods - - -
    Operating gross profit (loss), net 167,375 480,168 448,488
    Operating expenses 152,200 457,839 423,186
    Other gain (loss), net - - -
    Operating profit (loss) 15,175 22,329 25,302
    Non-operating income and expenses -3,671 -297 -2,177
    Net profit (loss) before tax 11,504 22,032 23,125
    Income tax expense (benefits) 1,651 3,458 4,860
    Net profit (loss) of ongoing business for the current period 9,853 18,574 18,265
    Profit (loss) of closed units - - -
    Profit (loss) of non-jointly controlled equity before merger - - -
    Net profit (loss) for the current period 9,853 18,574 18,265
    Other comprehensive profit (loss), net 15 -537 184
    Comprehensive net profit and loss of non-jointly controlled equity before merger - - -
    Total comprehensive profit and loss for the current period 9,868 18,037 18,449
    Net profit (loss) attributable to owners of parent company 9,853 18,574 18,265
    Net profit (loss) form equity attributable to former owner of business combination under common control - - -
    Net profit (loss) attributable to non-controlling interests - - -
    Comprehensive profit (loss) attributable to owners of parent company 9,868 18,037 18,449
    Comprehensive profit (loss) form equity attributable to former owner of business combination under common control - - -
    Comprehensive profit (loss) attributable to non-controlling interests - - -
    Basic earnings per share (yuan) 0 0 0
    項目 2024 2023 2022
    Net cash inflow (outflow) from operating activities 78,463 -37,537 52,240
    Net cash inflows (outflows) from investing activities -205,504 -4,518 -8,093
    Net cash inflow (outflow) from financing activities -3,784 456,300 -12,436
    Effect of Exchange Rate Changes on Cash and Cash Equivalents 15 41 -121
    Increase (decrease) in cash and cash equivalents in the current period -130,810 414,286 31,590
    Beginning balance of cash and cash equivalents 504,131 89,845 58,255
    Ending balance of cash and cash equivalents 373,321 504,131 89,845
    項目 2024 2023 2022
    Current asset 923,966 981,153 513,739
    Non-current asset 345,891 341,769 349,133
    Total asset 1,269,857 1,322,922 862,872
    Current liability 153,173 198,378 224,843
    Non-current liability 68,603 69,502 101,356
    Total liability 221,776 267,880 326,199
    share capital 590,486 590,486 475,923
    Equity - secruity token - - -
    capital reserve 415,772 415,772 13,822
    retained earning 41,877 48,853 47,038
    Other equity -54 -69 -110
    Treasury stock - - 0
    Total equity attributable to owners of parent company 1,048,081 1,055,042 536,673
    Equity attributable to former owner of business combination under common control - - -
    Equity attributable to non-controlling interest before business merger under common control - - -
    Non-controlling interests - - -
    Total Equity 1,048,081 1,055,042 536,673
    Share capital awaiting retirement (unit: share) 0 0 0
    Issued shares of advance equity (unit: shares) 0 0 0
    Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) 0 0 0
    Net asset value per share 17 17 11
    動產抵押
    下載完整報告查看完整數據
    案件類別 債務人名稱 債務人統編 契約啟始日期 契約終止日期 抵押權人名稱 抵押權人統編 擔保債權金額
    選舉收入(政治獻金)
    收入名稱 收入金額
    總收入金額
    選舉支出(政治獻金)
    支出名稱 支出金額
    總支出金額
    標案拒往
    機關名稱 生效日期 截止日期
    進出口資料
    下載完整報告查看完整數據
    年份 月份 總進口實績(美金) 總出口實績(美金)
    商標
  • 機本生活渼妍
  • 莓關C呵護飲
  • 渼光燈NMN膠原蛋白
  • Vitammy
  • LivPhcD
  • 輕甘酯
  • 暢晨
  • 拾光享睡飲
  • CATCHIMERA
  • 正甘能
  • 專利
    政府標案
    標案名稱 機關名稱 決標日期 決標金額 是否得標
    裁判書查詢
  • Others
    2007
  • Appointment of inspectors
    2007
  • Confirmation that the resolution of the shareholders' meeting is invalid, etc.
    2007
  • Others
    2007, 2009, 2010, 2011
  • Invalidating Judgment
    2019
  • Compensation for damage
    2010
  • Invalidating Judgment (Note)
    2018
  • Petition filed for public summons
    2018
  • 勞權違規
    日期 違反法規法條 罰鍰金額
    污染源裁處
    污染類別 裁處時間 裁處機關 裁處金額 違反事實 違反法令 裁處書字號 裁處理由及法令 公司地址
    本頁內所載之資料,所載資料之完整性、即時性和正確性仍應以資料來源單位為準。
    公司一有新動態,我們馬上通知你,追蹤公司讓你不錯過任何更新。